Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
5-Azacytidine Triggers ATR-Mediated DNA Damage in Myeloma Ce
2026-04-22
This study reveals that 5-azacytidine, a DNA methyltransferase inhibitor, induces ATR-mediated DNA double-strand break responses and apoptosis in multiple myeloma cells. The work provides mechanistic insight into its synergy with doxorubicin and bortezomib, supporting rationale for clinical evaluation of combination therapies.
-
Pleuromutilin-Ribosome Interactions and Resistance Mechanism
2026-04-22
This study dissects how pleuromutilin antibiotics, including semisynthetic derivatives, bind the ribosomal peptidyl transferase center and how distinct ribosomal mutations confer resistance. By integrating chemical footprinting with structural analysis, the paper reveals critical insights for rational antibiotic design and future resistance monitoring.
-
Coumestrol: Phytoestrogen Estrogen Receptor Antagonist for R
2026-04-21
Coumestrol, a potent phytoestrogen estrogen receptor antagonist, enables precise modulation of estrogen and nuclear receptor pathways in autoimmune and endocrine research. Recent breakthroughs in rheumatoid arthritis models showcase its dual roles in anti-proliferative signaling and ferroptosis induction, setting new protocol standards for translational workflows.
-
Gentamycin Sulfate: Applied Workflows for Resistance Researc
2026-04-21
Gentamycin Sulfate is a cornerstone aminoglycoside antibiotic for dissecting bacterial protein synthesis and resistance mechanisms in Gram-negative pathogens. This article offers stepwise protocols, troubleshooting insights, and evidence-driven guidance to maximize the reliability of resistance modeling and ribosome-targeted research.
-
Vitamin C (CAS 50-81-7): Precision Anticancer Protocols & Or
2026-04-20
Explore the advanced role of Vitamin C (ascorbic acid) in targeted anticancer protocols and organoid-based research. This in-depth analysis reveals unique mechanistic insights, practical assay parameters, and the impact of new organoid technology for cancer and antiviral studies.
-
Triiodothyronine (T3): Optimizing Metabolic and Adipocyte As
2026-04-20
Leverage Triiodothyronine (T3) for precision modulation of thyroid hormone signaling and advanced cellular metabolism workflows. This guide delivers actionable protocols, troubleshooting strategies, and research-driven insights for metabolic disorder and adipocyte differentiation studies.
-
L1023 Anti-Cancer Compound Library: Applied Workflows & Insi
2026-04-19
The L1023 Anti-Cancer Compound Library empowers researchers to interrogate oncogenic pathways and accelerate biomarker-driven drug discovery. This guide details data-driven workflows, troubleshooting strategies, and practical innovations inspired by recent advances in clear cell renal cell carcinoma research, highlighting how APExBIO’s curated collection streamlines complex screening applications.
-
PP 1: Src Family Tyrosine Kinase Inhibitor in Cancer Workflo
2026-04-18
PP 1 enables nanomolar-precision inhibition of Lck, Fyn, and RET kinases, providing researchers with an agile tool for dissecting complex oncogenic and immune signaling pathways. This guide details robust workflows, troubleshooting strategies, and translational insights for using PP 1 in advanced cancer and immunology research.
-
Quizartinib (AC220): Precision FLT3 Inhibition in AML Resear
2026-04-17
Quizartinib (AC220) from APExBIO empowers acute myeloid leukemia (AML) research by delivering nanomolar potency and selectivity in FLT3 inhibition. This article provides advanced workflows, troubleshooting strategies, and data-driven insights, translating recent findings on drug resistance and signaling into practical bench solutions.
-
HSP90 Inhibition Destabilizes METTL3 and Alters MYC m6A in C
2026-04-16
This study uncovers a novel regulatory axis in colorectal cancer: HSP90 stabilizes METTL3, which in turn maintains MYC mRNA m6A modification and expression. Pharmacological inhibition of HSP90 using 17-AAG triggers CHIP-mediated METTL3 degradation, reducing MYC m6A and impairing tumor cell phenotypes, highlighting new therapeutic opportunities and mechanistic insight for targeting mRNA modification in cancer.
-
CRISPR-Cas9 Editing of LGMN Suppresses Breast Cancer Metasta
2026-04-15
This study demonstrates that co-delivery of in vitro transcribed Cas9 mRNA and guide RNAs targeting the LGMN gene significantly impairs breast cancer cell metastasis. The work provides mechanistic insight into lysosomal/autophagic disruption and highlights the translational potential of RNA-based gene editing strategies for cancer.
-
Sildenafil Citrate: Optimized Workflows for cGMP-PDE5 Resear
2026-04-14
Sildenafil Citrate enables high-fidelity modulation of cGMP signaling and vascular smooth muscle relaxation, supporting advanced proteoform-specific research. This guide delivers actionable workflows, troubleshooting insights, and leverages the latest proteomic advances for superior assay precision and reproducibility.
-
Recombinant Mouse Sonic Hedgehog: Applied Workflows & Troubl
2026-04-13
APExBIO’s Recombinant Mouse Sonic Hedgehog (SHH) protein empowers precision modeling in limb, brain, and urogenital patterning studies. This guide distills cutting-edge experimental workflows, troubleshooting strategies, and actionable insights for optimizing SHH-driven developmental assays.
-
Applied Workflows with Anlotinib Hydrochloride: Multi-Target
2026-04-13
Anlotinib hydrochloride unlocks high-fidelity angiogenesis inhibition in advanced cancer research, outpacing legacy TKIs in selectivity and workflow versatility. This guide delivers actionable protocols, troubleshooting insights, and comparative context for optimizing endothelial assays and functional studies.
-
Precision Gene Expression Analysis: Mechanistic Insights for
2026-04-12
This thought-leadership article explores how mechanistic advances in hot-start Taq polymerase technology, as embodied in the HotStart™ Universal 2X Green qPCR Master Mix, are transforming translational gene expression analysis. Integrating mechanistic detail, evidence from recent animal nutrition studies, and practical guidance for translational researchers, it provides a roadmap for elevating data quality—from bench discovery to biomarker-driven applications. The discussion bridges foundational PCR mechanisms with the demands of complex biological models, offering differentiated, actionable insight beyond standard product overviews.